{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:10:19Z","timestamp":1759176619327},"reference-count":55,"publisher":"American Society for Microbiology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We previously showed that a multiple antigenic peptide (MAP) vaccine displaying amino acids (aa) 304 to 319 from the 2\u03b22-2\u03b23 loop of protective antigen was capable of protecting rabbits from an aerosolized spore challenge with<jats:named-content content-type=\"genus-species\">Bacillus anthracis<\/jats:named-content>Ames strain. Antibodies to this sequence, referred to as the loop-neutralizing determinant (LND), are highly potent at neutralizing lethal toxin yet are virtually absent in rabbit and human protective antigen (PA) antiserum. While the MAP vaccine was protective against anthrax, it contains a single heterologous helper T cell epitope which may be suboptimal for stimulating an outbred human population. We therefore engineered a recombinant vaccine (Rec-LND) containing two tandemly repeated copies of the LND fused to maltose binding protein, with enhanced immunogenicity resulting from the p38\/P4 helper T cell epitope from<jats:named-content content-type=\"genus-species\">Schistosoma mansoni<\/jats:named-content>. Rec-LND was found to be highly immunogenic in four major histocompatibility complex (MHC)-diverse strains of mice. All (7\/7) rabbits immunized with Rec-LND developed high-titer antibody, 6 out of 7 developed neutralizing antibody, and all rabbits were protected from an aerosolized spore challenge of 193 50% lethal doses (LD<jats:sub>50<\/jats:sub>) of the<jats:named-content content-type=\"genus-species\">B. anthracis<\/jats:named-content>Ames strain. Survivor serum from Rec-LND-immunized rabbits revealed significantly increased neutralization titers and specific activity compared to prechallenge levels yet lacked PA or lethal factor (LF) antigenemia. Control rabbits immunized with PA, which were also completely protected, appeared sterilely immune, exhibiting significant declines in neutralization titer and specific activity compared to prechallenge levels. We conclude that Rec-LND may represent a prototype anthrax vaccine for use alone or potentially combined with PA-containing vaccines.<\/jats:p>","DOI":"10.1128\/cvi.00612-12","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T07:18:22Z","timestamp":1357197502000},"page":"341-349","source":"Crossref","is-referenced-by-count":17,"title":["Recombinant Vaccine Displaying the Loop-Neutralizing Determinant from Protective Antigen Completely Protects Rabbits from Experimental Inhalation Anthrax"],"prefix":"10.1128","volume":"20","author":[{"given":"Jon","family":"Oscherwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp B.","family":"Cease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"key":"key20180919073643_B1","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","article-title":"Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia","volume":"61","author":"Cote","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"key20180919073643_B2","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"key20180919073643_B4","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/mt.2008.242","article-title":"Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors","volume":"17","author":"Liu","year":"2009","journal-title":"Mol. Ther."},{"key":"key20180919073643_B6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"key":"key20180919073643_B7","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/IAI.00899-09","article-title":"A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073643_B8","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/IAI.00358-09","article-title":"Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073643_B9","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1001749","article-title":"A synthetic peptide vaccine directed against the 2\u03b22-2\u03b23 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax","volume":"185","author":"Oscherwitz","year":"2010","journal-title":"J. Immunol."},{"key":"key20180919073643_B10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"key20180919073643_B11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"key20180919073643_B12","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B13","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1021\/bi990792d","article-title":"Anthrax protective antigen: prepore-to-pore conversion","volume":"38","author":"Miller","year":"1999","journal-title":"Biochemistry"},{"key":"key20180919073643_B14","doi-asserted-by":"crossref","first-page":"17186","DOI":"10.1016\/S0021-9258(18)41911-4","article-title":"Functional characterization of protease-treated Bacillus anthracis protective antigen","volume":"267","author":"Novak","year":"1992","journal-title":"J. Biol. Chem."},{"key":"key20180919073643_B15","doi-asserted-by":"crossref","first-page":"22090","DOI":"10.1074\/jbc.M010222200","article-title":"A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo","volume":"276","author":"Singh","year":"2001","journal-title":"J. Biol. Chem."},{"key":"key20180919073643_B16","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1016\/S0021-9258(19)62010-7","article-title":"The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor","volume":"269","author":"Singh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"key20180919073643_B17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15321810701454706","article-title":"Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine","volume":"28","author":"Gubbins","year":"2007","journal-title":"J. Immunoassay Immunochem."},{"key":"key20180919073643_B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"key20180919073643_B19","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/S0264-410X(99)00030-4","article-title":"A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein","volume":"17","author":"Oscherwitz","year":"1999","journal-title":"Vaccine"},{"key":"key20180919073643_B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/305029a0","article-title":"Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein","volume":"305","author":"Godson","year":"1983","journal-title":"Nature"},{"key":"key20180919073643_B21","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1073\/pnas.81.23.7520","article-title":"Circumsporozoite gene of Plasmodium cynomolgi (Gombak): cDNA cloning and expression of the repetitive circumsporozoite epitope","volume":"81","author":"Enea","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1073\/pnas.89.4.1239","article-title":"Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi","volume":"89","author":"Burns","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1172\/JCI116571","article-title":"Immunological recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis","volume":"92","author":"Klein","year":"1993","journal-title":"J. Clin. Invest."},{"key":"key20180919073643_B24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/eji.1830200720","article-title":"Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitope","volume":"20","author":"Lowenadler","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"key20180919073643_B25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0161-5890(92)90054-2","article-title":"T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions","volume":"29","author":"Lowenadler","year":"1992","journal-title":"Mol. Immunol."},{"key":"key20180919073643_B26","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/eji.1830231141","article-title":"Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope","volume":"23","author":"Lo-Man","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"key20180919073643_B27","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.vaccine.2005.10.046","article-title":"Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide","volume":"24","author":"Oscherwitz","year":"2006","journal-title":"Vaccine"},{"key":"key20180919073643_B28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.molimm.2010.01.026","article-title":"A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo","volume":"47","author":"Oscherwitz","year":"2010","journal-title":"Mol. Immunol."},{"key":"key20180919073643_B29","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.4049\/jimmunol.160.11.5420","article-title":"Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni","volume":"160","author":"Chen","year":"1998","journal-title":"J. Immunol."},{"key":"key20180919073643_B30","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073643_B31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"key20180919073643_B32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"key20180919073643_B33","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"key20180919073643_B34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-1759(88)90204-9","article-title":"An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity","volume":"106","author":"Rath","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"key20180919073643_B35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb. Pathog."},{"key":"key20180919073643_B36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4049\/jimmunol.106.3.872","article-title":"Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody","volume":"106","author":"Gershon","year":"1971","journal-title":"J. Immunol."},{"key":"key20180919073643_B37","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/IAI.00072-10","article-title":"An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans","volume":"78","author":"Ingram","year":"2010","journal-title":"Infect. Immun."},{"key":"key20180919073643_B38","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073643_B39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"key20180919073643_B40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"key20180919073643_B41","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073643_B42","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/AEM.00369-08","article-title":"Identification and characterization of Bacillus anthracis spores by multiparameter flow cytometry","volume":"74","author":"Schumacher","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"key20180919073643_B43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"key20180919073643_B44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"key20180919073643_B45","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073643_B46","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.vaccine.2011.12.010","article-title":"Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys","volume":"30","author":"Chabot","journal-title":"Vaccine"},{"key":"key20180919073643_B47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4161\/hv.5.8.8725","article-title":"Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults","volume":"5","author":"Keitel","year":"2009","journal-title":"Hum. Vaccin."},{"key":"key20180919073643_B48","doi-asserted-by":"crossref","DOI":"10.21236\/ADA403352","volume-title":"The anthrax vaccine: is it safe? Does it work?","author":"Joellenbeck","year":"2002"},{"key":"key20180919073643_B49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.712","article-title":"Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"11","author":"Sever","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"key20180919073643_B50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/653495","article-title":"Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge","volume":"202","author":"Crowe","year":"2010","journal-title":"J. Infect. Dis."},{"key":"key20180919073643_B51","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/IAI.01254-08","article-title":"Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed","volume":"77","author":"Reason","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073643_B52","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2008.05.023","article-title":"Domain specificity of the human antibody response to Bacillus anthracis protective antigen","volume":"26","author":"Reason","year":"2008","journal-title":"Vaccine"},{"key":"key20180919073643_B53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"The immunogenicity of Bacillus anthracis protective antigen domains and the efficacy of elicited antibody responses depend on host genetic background","volume":"15","author":"Abboud","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073643_B54","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073643_B55","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00612-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:01:37Z","timestamp":1687950097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00612-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,2]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,2,25]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1128\/CVI.00612-12"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00612-12","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,2]]}}}